Related references
Note: Only part of the references are listed.Discrimination of atypical parkinsonisms with transcranial magnetic stimulation
Alberto Benussi et al.
BRAIN STIMULATION (2018)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Valentina Garibotto et al.
NEUROBIOLOGY OF AGING (2017)
Clinical validity of presynaptic dopaminergic imaging with 123I- ioflupane and noradrenergic imaging with 123I- MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework
Ida Sonni et al.
NEUROBIOLOGY OF AGING (2017)
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
Niklas Mattsson et al.
NEUROBIOLOGY OF AGING (2017)
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia
Alberto Benussi et al.
NEUROLOGY (2017)
Outcomes after Diagnosis of Mild Cognitive Impairment in a Large Autopsy Series
Erin L. Abner et al.
ANNALS OF NEUROLOGY (2017)
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia
Alberto Benussi et al.
ANNALS OF NEUROLOGY (2016)
Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression
Giacomo Koch et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study
Marina Boccardi et al.
JAMA NEUROLOGY (2016)
Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee
P. M. Rossini et al.
CLINICAL NEUROPHYSIOLOGY (2015)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
Sandrine Andrieu et al.
LANCET NEUROLOGY (2015)
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
Barbara Borroni et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
Kaj Blennow et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Imaging markers for Alzheimer disease Which vs how
Giovanni B. Frisoni et al.
NEUROLOGY (2013)
Mild cognitive impairment: pathology and mechanisms
Elliott J. Mufson et al.
ACTA NEUROPATHOLOGICA (2012)
Relation of neuropathology to cognition in persons without cognitive impairment
David A. Bennett et al.
ANNALS OF NEUROLOGY (2012)
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients
Alessandro Martorana et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Motor Neuron dysfunction in frontotemporal dementia
James R. Burrell et al.
BRAIN (2011)
The Cholinergic System in Mild Cognitive Impairment and Alzheimer's Disease: An In Vivo MRI and DTI study
Stefan J. Teipel et al.
HUMAN BRAIN MAPPING (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration
Raffaele Nardone et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Short latency inhibition of human hand motor cortex by somatosensory input from the hand
H Tokimura et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)